Ms. Maximenko brings 15 years of human resources experience, having most recently served as the VP, Head of HR at Abeona Therapeutics where she was responsible for developing and executing people strategy and supporting the Company’s growth in a highly competitive gene therapy space. Prior to that she served as the Global HR Director and Head of HR for Advanced Accelerator Applications (AAAP), a Novartis company. Before the acquisition of AAAP by Novartis, she was responsible for more than 700 employees operating in a matrix environment within 11 International locations and in more than 20 US states.
Ms. Maximenko has hands-on experience setting up the HR function from the ground up in growing biotechs from pre-clinical to commercial stage and building out teams in various functional areas including R&D, Medical Affairs, Commercial, Quality, TechOps, and others. She’s got expertise in multiple HR disciplines, including talent acquisition, employee engagement, employee relations, organizational development and compensation.
Dr. McGarr is an expert in program management with over 25 years of experience leading drug development strategies and operations for many biotech and pharmaceutical companies. Prior to Dianthus, he served as Senior Director, Program and Portfolio Management, for ElevateBio, where he helped advance the development of cell and gene therapies of partners and portfolio companies. Previously, he was the Director, Program and Alliance Management, for Alnylam Pharmaceuticals, a Nobel Prize-winning company specialized in RNAi (RNA interference).
Dr. McGarr’s depth of leadership and management experience continues into his early career, when served as the Director of Alliance Management, Therapeutics Project Program, at Fred Hutch before becoming their Senior Director, Immunotherapy Operations and Alliance Management. Before Fred Hutch, he was the Senior Program Manager at the Infectious Disease Research Institute.